SEC Form 4 · accession 0001209191-17-019945
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Mark Marino
Officer — Chief Medical Officer
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $1.55 | Mar 8, 2017 | A | 42,000 | A | — | Mar 8, 2027 | Common Stock | 42,000 | 42,000 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the option shares shall vest and become exercisable on March 8, 2018 with the remaining option shares vesting and becoming exercisable in thirty-six (36) consecutive monthly installments.